Literature DB >> 12358371

Juvenile bone-marrow oedema of the acetabulum treated by iloprost.

N Aigner1, G Petje, W Schneider, C Krasny, F Grill, F Landsiedl.   

Abstract

The bone-marrow oedema syndrome is associated with local vascular disturbances and may be treated either conservatively or by core decompression after which recovery may take several weeks. We describe a 15-year-old girl with bone-marrow oedema of the left acetabulum which was confirmed by MRI. She presented with a four-week history of severe constant pain. Routine blood tests and plain radiographs were normal. She was treated with intravenous infusions of iloprost on five consecutive days (20 microg administered in 500 ml of sodium chloride). Iloprost causes vasodilatation with reduction of capillary permeability and it inhibits platelet aggregation. She had relief from pain at rest after three days of treatment and was completely free from symptoms after two weeks. MRI after six weeks showed almost complete resolution of the marrow oedema and was normal after four months. This is the first report of the pharmacological treatment of the bone-marrow oedema syndrome in children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358371     DOI: 10.1302/0301-620x.84b7.13175

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  13 in total

1.  Efficiency of iloprost treatment for osseous malperfusion.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Travis Matheney; Gordana Kozina; Dirk Blondin; Rüdiger Krauspe
Journal:  Int Orthop       Date:  2010-03-21       Impact factor: 3.075

2.  Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.

Authors:  Eric Röhner; Timo Zippelius; David Steindl; Jasmin Fussi; Carsten Perka
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-19

3.  Regional migratory osteoporosis: case report of a patient with neuropathic pain.

Authors:  Esin Kartal; Ebru Sahin; Banu Dilek; Meltem Baydar; Metin Manisali; Can Kosay; Selmin Gulbahar
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

Review 4.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

5.  Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost.

Authors:  Roland Meizer; Dominik Meraner; Elisabeth Meizer; Christian Radda; Franz Landsiedl; Nicolas Aigner
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

Review 6.  [Conservative treatment of aseptic necrosis of the femoral head. Are there evidence-based therapy concepts?].

Authors:  C Lüring; J Beckmann; P H Pennekamp; O Linhardt; J Grifka; M Tingart
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

7.  [Bone marrow edema syndrome (BMES)].

Authors:  B S Craiovan; C Baier; J Grifka; J Götz; J Schaumburger; J Beckmann
Journal:  Orthopade       Date:  2013-03       Impact factor: 1.087

8.  [Aseptic osteonecrosis in children and adolescents].

Authors:  E von Stillfried; M-A Weber
Journal:  Orthopade       Date:  2014-08       Impact factor: 1.087

9.  Neridronate for transient osteoporosis of the hip in a child.

Authors:  C Gaggiano; M Bardelli; M Tarsia; S Gentileschi; A Maselli; S Grosso; L Cantarini; B Frediani
Journal:  Osteoporos Int       Date:  2022-02-01       Impact factor: 5.071

10.  Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis.

Authors:  Tim Claßen; Antonia Becker; Stefan Landgraeber; Marcel Haversath; Xinning Li; Christoph Zilkens; Rüdiger Krauspe; Marcus Jäger
Journal:  Orthop Rev (Pavia)       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.